NEVVI Medicare utilization intelligence

← back

REED, MARKMD NPI 1477585347 Clinician

Gynecological Oncology · GERMANTOWN, TN

Specialty Gynecological Oncology — from billed Medicare claims
Trained UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 39 years since medical school (class of 1987, self-reported to CMS)
Location GERMANTOWN, TN · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 37 codes billed · 11,449 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
ECM HEALTH GROUP LLC
2025–2026
THE WEST CLINIC P.C.
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1437 Injection, ferric derisomaltose, 10 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80048 Blood test, basic group of blood chemicals (calcium, total)
80076 Liver function blood test panel
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96372 Injection of drug or substance under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
J3490 Unclassified drugs
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96375 Injection of additional new drug or substance into vein
83735 Magnesium level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
81003 Automated urinalysis test
J1200 Injection, diphenhydramine hcl, up to 50 mg
99459 Pelvic exam
58571 Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
38570 Biopsy and removal of lymph nodes of abdominal cavity using an endoscope
38900 Imaging of lymph nodes during surgery
82565 Blood creatinine level
56820 Exam of external female genitals using an endoscope
57420 Exam of vagina and cervix using an endoscope
85610 Blood test, clotting time
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg
58120 Dilation and scraping of uterus

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.